Aeluma offers a differentiated photonics technology, trading at low valuations due to missed sector rally and early-stage commercialization risks. ALMU's revenue is primarily from government R&D contracts, but commercial engagement is growing, with manufacturing partnerships and ongoing qualification processes. The technology addresses critical supply chain bottlenecks in AI infrastructure, with scalable manufacturing and strong demand, though qualification risk remains the primary hurdle.

